Detalhe da pesquisa
1.
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Cell
; 184(15): 3949-3961.e11, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161776
2.
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Cell
; 183(3): 739-751.e8, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991842
3.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Cell
; 174(4): 938-952.e13, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096313
4.
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Nature
; 593(7857): 130-135, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33684923
5.
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Nature
; 595(7868): 572-577, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044428
6.
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 586(7830): 594-599, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32998157
7.
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
N Engl J Med
; 385(6): 493-502, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215024
8.
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19.
N Engl J Med
; 384(3): 238-251, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332778
9.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med
; 385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347950
10.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
N Engl J Med
; 385(23): e81, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587383
11.
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
J Infect Dis
; 225(10): 1765-1772, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507266
12.
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Nature
; 590(7844): E17, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469214
13.
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies.
Mol Ther
; 29(12): 3512-3524, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34400331
14.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA
; 327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35029629
15.
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
Clin Infect Dis
; 73(11): e4400-e4408, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32897368
16.
Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice.
J Immunol
; 198(3): 1047-1055, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011932
17.
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates.
J Infect Dis
; 218(suppl_5): S612-S626, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860496
18.
CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome.
J Virol
; 91(1)2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795435
19.
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.
Proc Natl Acad Sci U S A
; 112(28): 8738-43, 2015 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124093
20.
Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development.
Proc Natl Acad Sci U S A
; 112(37): E5116, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318164